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The Inoue balloon (InI catheter consists of a 
single balloon which inflates in 3 stages as result of 
~~ffe~~~t~a~ compliance characteristics. Because 
previous experience with %nB for percutaneous mitral 
Valve WV) ballOOn ValVUlOplasty (BV) has been largely 
limited to Oriental pts, a multi-center investigation 
wa3 undertaken to assess efficacy and refety of PnB in 
North American WA) pts. Initial 23 NA pts included 20 
women and 3 men ages 32 to 87 (m44). MV was calcified 
in 18/23 (=78%8. 1B-l 1 pt, lnB could not be advanced 
acxoss WI. In remaining 22 pts mean wedge (PCW) or left 
MV area (MVA) 
ostBV 20.lftS.B* 
roeedural. co ns (cx) included development of 
2+/4+ mitral 
r!lecbiwe WV ent in 2/3. 
other procedural cx was 1 TIA. Subjective operator 
assessment indicated that novel design of InB greatly 
facilitated performance of BV. Conclusion: This 
preliminary data suggests: InB aI is efficacious, b) 
does not preclude MR as cx of BV, and c) may be 
associated with otherwise low risk of procedural cx in 
NW pts. Long-term efficacy remains to be determined. 
was carried out in 17 
patients and CC in 11. Doppler EC io~rapby was used to calculate 
mitral valve gradient (MVG) by modified Bemouilli-equation and milral valve 
area (Cm) ) (MVA) using the prt?~~urc half time method. The measurements 
were made l-2 days before (II) and 7-10 both procedures. The 
presence or absence of mitral regurgitat also studied. Doppler 
MV& MVG, and % change were as lo are reported as mean 
f one standard deviation. 
&E % % 
a - increase A reductiotj 
v 30.9-cl 1.0,90.4 1.7EtzO.1 15.0*5 &Of3 47 
CC 27.5~~6 0.9kO.2 1.5zk8.2 18.2z?z5 10.5Ltz3 42 
ital mortality in ei:her g:ssp. 
e increase in MVA and 
(p=NS) in both grorrps. 
balloon or surgically treated. 
hemodynamic improvement, their clinical stf3tus 6 months 
after PkV Ls. markedly improved. 
